<?xml version="1.0" encoding="UTF-8"?>
<ref id="R30">
 <label>30</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <string-name>
    <surname>Kubo</surname>
    <given-names>M</given-names>
   </string-name>, 
   <string-name>
    <surname>Satoh</surname>
    <given-names>T</given-names>
   </string-name>, 
   <string-name>
    <surname>Ishiyama</surname>
    <given-names>H</given-names>
   </string-name>, 
   <etal>et al</etal>
  </person-group>. 
  <article-title>Enhanced activated T cell subsets in prostate cancer patients receiving iodine-125 low-dose-rate prostate brachytherapy</article-title>. 
  <source>Oncol Rep</source>
  <year>2018</year>;
  <volume>39</volume>:
  <fpage>417</fpage>â€“
  <lpage>24</lpage>. 
  <pub-id pub-id-type="doi">10.3892/or.2017.6095</pub-id>
  <?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/29138841?>
  <pub-id pub-id-type="pmid">29138841</pub-id>
 </mixed-citation>
</ref>
